SkinBioTherapeutics plc (LON:SBTX – Get Free Report) traded up 10.2% during mid-day trading on Friday . The stock traded as high as GBX 12.50 ($0.16) and last traded at GBX 12.40 ($0.16). 2,169,667 shares traded hands during trading, an increase of 147% from the average session volume of 877,841 shares. The stock had previously closed at GBX 11.25 ($0.15).
SkinBioTherapeutics Stock Performance
The firm has a market capitalization of £28.49 million, a price-to-earnings ratio of -630.00 and a beta of 2.01. The company has a 50-day moving average price of GBX 11.95 and a 200-day moving average price of GBX 10.64. The company has a quick ratio of 10.01, a current ratio of 6.57 and a debt-to-equity ratio of 2.66.
About SkinBioTherapeutics
SkinBioTherapeutics plc, a life science company, engages in identification and development of technology that harnesses the human microbiome to improve health in the United Kingdom, the United States, and Europe. It develops SkinBiotix technology that promotes skin health by harnessing the beneficial properties of probiotic bacteria and the active components; and AxisBiotix technology that focuses on the gut-skin relationship and is designed to alleviate the symptoms associated with psoriasis.
Recommended Stories
- Five stocks we like better than SkinBioTherapeutics
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Mid-Cap Stocks Under $20 With Insider Buying and Major Upside
- Best Stocks Under $5.00
- China’s EV Rally: Should Investors Chase, Avoid, or Buy the Dip?
- What is the Nasdaq? Complete Overview with History
- MarketBeat Week in Review – 10/7 – 10/11
Receive News & Ratings for SkinBioTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SkinBioTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
